Atlas Trials

NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC

Clinical trial NCT07295262 · RECRUITING

Trial details

NCT number
NCT07295262
Sponsor
West China Hospital
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Liver Cancer, Adult
Start date
2026-01-01
Primary completion
2028-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.